- Report
- February 2025
- 200 Pages
Global
From €3988EUR$4,490USD£3,461GBP
- Report
- February 2025
- 200 Pages
Global
From €3988EUR$4,490USD£3,461GBP
- Report
- January 2025
- 200 Pages
Global
From €3988EUR$4,490USD£3,461GBP
- Report
- September 2025
- 278 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- January 2025
- 185 Pages
Global
From €3997EUR$4,500USD£3,468GBP
- Report
- November 2024
- 183 Pages
Global
From €3997EUR$4,500USD£3,468GBP
- Report
- September 2025
- 276 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- September 2025
- 377 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- September 2025
- 191 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- September 2025
- 389 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- September 2025
- 376 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- September 2025
- 588 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- September 2025
- 282 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- September 2025
- 196 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- September 2025
- 474 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- September 2025
- 413 Pages
Global
From €5196EUR$5,850USD£4,509GBP
- Report
- December 2024
- 200 Pages
Global
From €3331EUR$3,750USD£2,890GBP
- Report
- January 2025
- 180 Pages
Global
From €3997EUR$4,500USD£3,468GBP
- Report
- May 2025
- 154 Pages
Global
From €4219EUR$4,750USD£3,661GBP
- Report
- May 2025
- 115 Pages
Global
From €4219EUR$4,750USD£3,661GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more